Search

everythinglearnresearchcommunity

for

Search:↓

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Erianin may effectively treat alopecia areata by targeting the immune system.

Minoxidil can help regrow hair in people with alopecia areata.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Certain gut bacteria may protect against alopecia areata, while others may increase the risk.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

The combination of laser and topical steroids is more effective for treating alopecia areata than topical steroids alone.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

The combined laser and plasma jet therapy effectively regrew hair in a woman with alopecia areata.

The role of γδT-cells in causing alopecia areata remains unclear.

Exosomes helped regrow hair in a 14-year-old with difficult-to-treat alopecia.

Ginger extract helps hair growth and reduces the need for prednisolone in alopecia areata patients.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Alopecia areata may lead to hearing loss.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.